uncommonbio
Uncommon (uncommonbio.co, formerly Higher Steaks) is a Cambridge, UK biotechnology company backed by Balderton Capital. The company sold its cultivated meat platform to Vow and has pivoted to launch SymphoRNA, a new venture developing nucleic acid delivery technology for multi-RNA combination medicines that target complex diseases such as fibrosis, heart failure, and neurodegeneration. As a life-sciences research and platform company, Uncommon publishes no public developer program, API, or machine-readable API specification. This profile was added to the API Evangelist network as a portfolio lead of Balderton Capital and enriched via the local enrichment pipeline, which confirmed the absence of an API surface while capturing live domain-security posture.
uncommonbio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Nucleic Acid Delivery, and RNA Therapeutics.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API